Owkin Stock
HealthTechLooking to sell Owkin stock or options?
Owkin develops machine learning tools aimed at enhancing medical and biological research. Owkin's platform uses AI to comprehend complex biology, identify new treatments, and streamline clinical trials, aiding drug discovery and diagnostics deployment. This enables pharmaceutical companies to assess drug efficacy variations, refine the drug development process, and enhance treatment outcomes.
Third Kind Venture Capital, Key Ventures, Otium Capital, Jean-Paul Clozel, F-Prime Capital, NJF Capital, Jorg Mohaupt, Brent Hoberman, Bpifrance, Sanofi, Google for Startups, Eight Roads, Cathay Capital Private Equity, Groupe MACSF, Frst Capital, Joël Besse, Cathay Innovation, Plug and Play Tech Center, GV, Mubadala Capital, Bristol-Myers Squibb.